C11H7BrO4, triclinic, P1 (no. 2), a = 4.3164(5) Å, b = 10.7922(12) Å, c = 11.1521(11) Å, α = 98.075(4)°, β = 100.741(4)°, γ = 95.325(5)°, V = 501.55(9) Å 3 , Z = 2, Rgt(F) = 0.0203, wR ref (F 2 ) = 0.0544, T = 200(2) K.
Experimental details
Carbon-bound H atoms were placed in calculated positions and were included in the refinement in the riding model approximation, with U(H) set to 1.2 Ueq(C). The H atoms of the methyl group were allowed to rotate with a fixed angle around the C-C bond to best fit the experimental electron density (HFIX 137 [2] ), with U iso (H) set to 1.5 Ueq(C).
Comment
Coumarin derivatives constitute the core structure of various natural products and are often the vital pharmacophore that originate in numerous medicinal agents such as antimicrobial, antifungal and antioxidant agents [7, 8] . Special properties of coumarin derivatives are of interest as targets to organic chemists and serve as intermediates in the synthesis of novel biological active compounds. In addition, certain derivatives of coumarins are known to induce apoptosis by cytochrome C release and caspase activation [9] . Recent reports describe some coumarin derivatives such as 7-hydroxy-coumarin [10] , 7,8-diacetoxy-4-methylcoumarin and 7,8-diacetoxy-4-methylcoumarin [11, 12] with selective cytotoxicity to cancer cells, which inhibit the growth of lung cancer cells without damaging the growth of normal peripheral blood mononuclear cells.
The title compound exhibits strong intramolecular hydrogen bonding of the O-H· · · O type between the hydroxy group and the ketonic O atom [O-O = 2.428(2) Å; see the figure]. The packing of crystal structure is dominated by weak intermolecular interactions. Additional π-π stacking interactions between adjacent rings (centroid distance is 3.331(2) Å) further stabilize the crystal.
